Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma

Por Charoentum, Chaiyut, Thongprasert, Sumitra, Chewaskulyong, Busyamas, Munprakan, Sutthirak
Publicado no World J Gastroenterol (2007)

Update on Anti-EGFR Therapy

Por Chua, Daniel, Fasching, Peter, Ma, Brigette, Thongprasert, Sumitra, Wirth, Lori
Publicado em 2009

Prevalence and relationship between major depressive disorder and lung cancer: a cross-sectional study

Por Maneeton, Benchalak, Maneeton, Narong, Reungyos, Jirayu, Intaprasert, Suthi, Leelarphat, Samornsri, Thongprasert, Sumitra
Publicado em 2014

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

Por Shi, Yuankai, Au, Joseph Siu-Kie, Thongprasert, Sumitra, Srinivasan, Sankar, Tsai, Chun-Ming, Khoa, Mai Trong, Heeroma, Karin, Itoh, Yohji, Cornelio, Gerardo, Yang, Pan-Chyr
Publicado em 2014

Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study

Por Vansteenkiste, Johan F., Canon, Jean-Luc, De Braud, Filippo, Grossi, Francesco, De Pas, Tommaso, Gray, Jhanelle E., Su, Wu-Chou, Felip, Enriqueta, Yoshioka, Hiroshige, Gridelli, Cesare, Dy, Grace K., Thongprasert, Sumitra, Reck, Martin, Aimone, Paola, Vidam, Gena Atalla, Roussou, Pantelia, Wang, Ying A., Tomaso, Emmanuelle Di, Soria, Jean-Charles
Publicado no J Thorac Oncol (2015)